Baker Bros. Advisors’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-45,027
| Closed | -$213K | – | 92 |
|
|
2024
Q4 | $213K | Hold |
45,027
| – | – | ﹤0.01% | 93 |
|
|
2024
Q3 | $419K | Hold |
45,027
| – | – | ﹤0.01% | 90 |
|
|
2024
Q2 | $259K | Hold |
45,027
| – | – | ﹤0.01% | 93 |
|
|
2024
Q1 | $302K | Hold |
45,027
| – | – | ﹤0.01% | 83 |
|
|
2023
Q4 | $290K | Hold |
45,027
| – | – | ﹤0.01% | 81 |
|
|
2023
Q3 | $225K | Hold |
45,027
| – | – | ﹤0.01% | 100 |
|
|
2023
Q2 | $317K | Hold |
45,027
| – | – | ﹤0.01% | 105 |
|
|
2023
Q1 | $279K | Hold |
45,027
| – | – | ﹤0.01% | 102 |
|
|
2022
Q4 | $287K | Hold |
45,027
| – | – | ﹤0.01% | 107 |
|
|
2022
Q3 | $386K | Hold |
45,027
| – | – | ﹤0.01% | 109 |
|
|
2022
Q2 | $612K | Hold |
45,027
| – | – | ﹤0.01% | 106 |
|
|
2022
Q1 | $686K | Hold |
45,027
| – | – | ﹤0.01% | 113 |
|
|
2021
Q4 | $1.03M | Buy |
+45,027
| New | +$1.03M | 0.01% | 116 |
|